Moderna, Inc. — Director's Dealing 2020

Jul 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-07-01

Reporting Person: Tallett Elizabeth E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-01	Stock Option (Right to Buy)	$61.59	A	12590	Acquired	2030-07-01	Common Stock (12590)	Direct
2020-07-01	Stock Option (Right to Buy)	$61.59	A	11229	Acquired	2030-07-01	Common Stock (11229)	Direct

Footnotes

F1: This option will be fully vested and exercisable on July 1, 2021.

F2: This option will become fully vested and exercisable on the earlier of April 29, 2021, or the next Annual Meeting of Stockholders, subject to the recipient's continued service.